Nama Insights

KraneShares MSCI All China Health Care Index ETF (KURE)

Greater China Region · KraneShares · NYSE

Greater China RegionETF
KraneShares MSCI All China Health Care Index ETF (KURE) is an exchange-traded fund in the Greater China Region category. It has $109.25M in assets, an expense ratio of 0.65% and a 3.86% dividend yield. The fund will invest at least 80% of its net assets (plus borrowings for investment purposes) in instruments in its underlying index or in instruments that have economic characteristics similar to those in the underlying index. The underlying index is a free float adjusted market capitalization weighted index, subject to the 10/40 Constraint, which is designed to measure the equity market performance of Chinese companies in the healthcare sector. The fund is non-diversified.
Assets under management$109.25M
Expense ratio0.65%
CategoryGreater China Region
Dividend yield3.86%
NAV$18.34
Fund familyKraneShares
ExchangeNYSE

Top holdings

The largest positions KraneShares MSCI All China Health Care Index ETF reports, by weight.

HoldingNameWeight
1801.HK Innovent Biologics Inc 9.39%
6160.HK BeOne Medicines Ltd Ordinary Shares 8.75%
2269.HK WuXi Biologics (Cayman) Inc 7.29%
603259.SS Wuxi AppTec Co Ltd Class A 5.46%
300760.SZ Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A 4.63%
1177.HK Sino Biopharmaceutical Ltd 3.79%
600276.SS Jiangsu Hengrui Pharmaceuticals Co Ltd Class A 3.63%
1093.HK CSPC Pharmaceutical Group Ltd 3.59%
9926.HK Akeso Inc Ordinary Shares 3.54%
02359 Wuxi AppTec Co Ltd 3.17%

Other Greater China Region ETFs

Explore live KURE data on Nama Insights →